| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 77, 1084-1089, Copyright © 1993 by Endocrine Society
ARTICLES |
T Nishikawa, S Yamashita, H Namba, T Usa, T Tominaga, H Kimura, M Izumi and S Nagataki
First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
To evaluate the role of interferon-gamma (IFN gamma) on human thyroid- specific gene expression, the effect of IFN gamma on TSH- and cAMP- induced TSH receptor gene expression was studied using cultured thyroid cells obtained from normal thyroid glands and those from patients with Graves' disease. Incubation of Graves' thyroid cells with 1.0 U/L bovine TSH or 1.0 mM 8-bromo-cAMP resulted in a 2-fold increase in TSH receptor mRNA expression, which was markedly inhibited in the presence of IFN gamma in a dose- and time-dependent manner. This inhibitory effect was completely neutralized by monoclonal antibody against IFN gamma. IFN alpha and -beta had no influence on TSH- and cAMP-stimulated TSH receptor mRNA expression. Paranodular normal thyroid cells showed the same results as those obtained using Graves' thyroid cells. Scatchard analysis of the [125I]TSH binding study showed that IFN gamma inhibited the number of TSH receptors up-regulated by TSH on the cell surface at the low affinity binding site (4.1 vs. 8.2 x 10(5)/cell). These results indicate that IFN gamma suppresses TSH- and cAMP stimulated human TSH receptor gene expression, resulting in a decrease in the number of TSH receptors. In conclusion, IFN gamma interacts via an intermediate pathway of TSH signal transduction and attenuates TSH receptor synthesis in normal and Graves' thyroid cells.
This article has been cited by other articles:
 |
|
 |
|
  L. Barzon, M. Boscaro, and G. Palu Endocrine Aspects of Cancer Gene Therapy Endocr. Rev., February 1, 2004; 25(1): 1 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Mead, T. R. Hughes, S. A. Irvine, N. N. Singh, and D. P. Ramji Interferon-gamma Stimulates the Expression of the Inducible cAMP Early Repressor in Macrophages through the Activation of Casein Kinase 2. A POTENTIALLY NOVEL PATHWAY FOR INTERFERON-gamma -MEDIATED INHIBITION OF GENE TRANSCRIPTION J. Biol. Chem., May 9, 2003; 278(20): 17741 - 17751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Arao, I. Morimoto, A. Kakinuma, O. Ishida, K. Zeki, Y. Tanaka, N. Ishikawa, K. Ito, K. Ito, and S. Eto Thyrocyte Proliferation by Cellular Adhesion to Infiltrating Lymphocytes through the Intercellular Adhesion Molecule-1/Lymphocyte Function-Associated Antigen-1 Pathway in Graves' Disease J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 382 - 389. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Miyazaki, H. Shimura, T. Endo, K. Haraguchi, and T. Onaya Tumor Necrosis Factor-{alpha} and Interferon-{gamma} Suppress Both Gene Expression and Deoxyribonucleic Acid-Binding of TTF-2 in FRTL-5 Cells Endocrinology, September 1, 1999; 140(9): 4214 - 4220. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Caturegli, M. Hejazi, K. Suzuki, O. Dohan, N. Carrasco, L. D. Kohn, and N. R. Rose Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid PNAS, February 15, 2000; 97(4): 1719 - 1724. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
